A novel anti-cancer therapy with nuclear export inhibitor Selinexor in combination with oncolytic myxoma virus
M. M. Rahman, F. v. Oosterom, J. A. Enow, M. Hossain, A. D. Gutierrez-Jensen, M. Cashen, A. Everts, K. Lowe, J. Kilbourne, J. Daggett-Vondras, T. L. Karr, G. McFadden
This study shows that combining Selinexor with oncolytic myxoma virus enhances virus replication and cancer cell killing in vitro and in vivo.
bioRxiv · Oct 31, 2022 · PreprintMicrobiology